展開選單
關於國鼎
企業理念
團隊陣容
發展沿革
合作夥伴
研究
Antroquinonol
臨床進度
臨床試驗
支援文獻
關於阿茲海默症
新聞中心
新聞消息
活動消息
業務發展
投資人專區
重大訊息
財務資訊
公司治理
股東專區
聯絡我們
搜尋
繁中
EN
收合選單
搜尋
TW
繁體中文
English
HOME
研究
支援文獻
支援文獻
Oncology
A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimen.
Lee YC. et al, Molecular and Clinical Oncology. DOI: 10.3892/mco.2015.642
Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles
Kumar VB. et al, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. DOI: 10.1016/j.mrfmmm.2010.12.009
Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: A crucial role of AMPK and mTOR pathways.
Chiang PC. et al, Biochemical Pharmacology. DOI: 10.1016/j.bcp.2009.08.022
Hypermethylation of CCND2 in lung and breast cancer is a potential biomarker and drug target.
Hung CS. et al, International Journal of Molecular Sciences. DOI: 10.3390/ijms19103096
Antroquinonol blocks Ras and Rho signaling via the inhibition of protein isoprenyltransferase activity in cancer cells.
Ho CL. et al, Biomedicine and Pharmacotherapy. DOI: 10.1016/j.biopha.2014.09.008
Antroquinonol targets FAK-signaling pathway suppressed cell migration, invasion, and tumor growth of C6 glioma.
Thiyagarajan V. et al, PLoS ONE. DOI: 10.1371/journal.pone.0141285
Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting ERK-AP-1- and AKT-NF-κB-dependent MMP-9 and epithelial-mesenchymal transition expressions.
Lee WT. et al, Food and Chemical Toxicology. DOI: 10.1016/j.fct.2015.01.012
Antroquinonol, a ubiquinone derivative from the mushroom Antrodia camphorata, inhibits colon cancer stem cell-like properties: Insights into the molecular mechanism and inhibitory targets.
Lin HC. et al, Journal of agricultural and food chemistry. DOI: 10.1021/acs.jafc.6b04101
Neurodegenerative Disease
Antroquinonol lowers brain amyloid-β levels and improves spatial learning and memory in a transgenic mouse model of Alzheimer's disease.
Chang WH. et al, Scientific Reports. DOI: 10.1038/srep15067
Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology.
Francesca F. et al, Brain, Behavior, & Immunity - Health. DOI: 10.1016/j.bbih.2022.100435